Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ben Goldacre"'
Autor:
Laurie A. Tomlinson, Chris Bates, Seb Bacon, Elizabeth A. Williamson, Amir Mehrkar, Krishnan Bhaskaran, Henry Drysdale, Richard Croker, Liam Smeeth, Angel Y S Wong, William J Hulme, Rosalind M Eggo, Jonathan Cockburn, Ben Goldacre, Stephen J. W. Evans, Caroline E Morton, Helen J Curtis, Peter Inglesby, Sam Harper, John Parry, Frank Hester, Anna Schultze, Helen Mcdonald, Christopher T Rentsch, Kevin Wing, Alex J Walker, Ian J. Douglas, Harriet Forbes, David M. Evans, Rohini Mathur, Brian MacKenna, Jeremy P Brown
Publikováno v:
Annals of the Rheumatic Diseases
Wong, AY, MacKenna, B, Morton, CE, Schultze, A, Walker, AJ, Bhaskaran, K, Brown, JP, Rentsch, CT, Williamson, E, Drysdale, H, Croker, R, Bacon, S, Hulme, W & Collaborative, OAFELY 2021, ' Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19 : an OpenSAFELY cohort analysis based on two cohorts ', Annals of the Rheumatic Diseases, vol. 80, no. 7, pp. 943-951 . https://doi.org/10.1136/annrheumdis-2020-219517
Wong, A Y S, MacKenna, B, Morton, C E, Schultze, A, Walker, A J, Bhaskaran, K, Brown, J P, Rentsch, C T, Williamson, E, Drysdale, H, Croker, R, Bacon, S, Hulme, W, Bates, C, Curtis, H J, Mehrkar, A, Evans, D, Inglesby, P, Cockburn, J, McDonald, H I, Tomlinson, L, Mathur, R, Wing, K, Forbes, H, Eggo, R M, Parry, J, Hester, F, Harper, S, Evans, S J W, Smeeth, L, Douglas, I J & Goldacre, B 2021, ' Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19 : An OpenSAFELY cohort analysis based on two cohorts ', Annals of the Rheumatic Diseases, vol. 80, no. 7, pp. 943-951 . https://doi.org/10.1136/annrheumdis-2020-219517
Wong, AY, MacKenna, B, Morton, CE, Schultze, A, Walker, AJ, Bhaskaran, K, Brown, JP, Rentsch, CT, Williamson, E, Drysdale, H, Croker, R, Bacon, S, Hulme, W & Collaborative, OAFELY 2021, ' Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19 : an OpenSAFELY cohort analysis based on two cohorts ', Annals of the Rheumatic Diseases, vol. 80, no. 7, pp. 943-951 . https://doi.org/10.1136/annrheumdis-2020-219517
Wong, A Y S, MacKenna, B, Morton, C E, Schultze, A, Walker, A J, Bhaskaran, K, Brown, J P, Rentsch, C T, Williamson, E, Drysdale, H, Croker, R, Bacon, S, Hulme, W, Bates, C, Curtis, H J, Mehrkar, A, Evans, D, Inglesby, P, Cockburn, J, McDonald, H I, Tomlinson, L, Mathur, R, Wing, K, Forbes, H, Eggo, R M, Parry, J, Hester, F, Harper, S, Evans, S J W, Smeeth, L, Douglas, I J & Goldacre, B 2021, ' Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19 : An OpenSAFELY cohort analysis based on two cohorts ', Annals of the Rheumatic Diseases, vol. 80, no. 7, pp. 943-951 . https://doi.org/10.1136/annrheumdis-2020-219517
Objectives To assess the association between routinely prescribed non-steroidal anti-inflammatory drugs (NSAIDs) and deaths from COVID-19 using OpenSAFELY, a secure analytical platform.Methods We conducted two cohort studies from 1 March to 14 June 2
Autor:
Ben Goldacre, Georgia C. Richards, Nicholas J DeVito, Tonny Brian Muthee, Constantinos Koshiaris, Carl Heneghan, Kamal R Mahtani, Jeffrey K Aronson
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-11 (2020)
BMC Medicine
BMC Medicine
Background The risks of harms from opioids increase substantially at high doses, and high-dose prescribing has increased in primary care. However, little is known about what leads to high-dose prescribing, and studies exploring this have not been syn
Autor:
The OpenSAFELY Collaborative, Angel Y. S. Wong, Laurie A. Tomlinson, Jeremy P. Brown, William Elson, Alex J. Walker, Anna Schultze, Caroline E. Morton, David Evans, Peter Inglesby, Brian MacKenna, Krishnan Bhaskaran, Christopher T. Rentsch, Emma Powell, Elizabeth Williamson, Richard Croker, Seb Bacon, William Hulme, Chris Bates, Helen J. Curtis, Amir Mehrkar, Jonathan Cockburn, Helen I. McDonald, Rohini Mathur, Kevin Wing, Harriet Forbes, Rosalind M. Eggo, Stephen J. W. Evans, Liam Smeeth, Ben Goldacre, Ian J. Douglas
Publikováno v:
Journal of Hematology & Oncology
Wong, A Y S, Tomlinson, L A, Brown, J P, Elson, W, Walker, A J, Schultze, A, Morton, C E, Evans, D, Inglesby, P, MacKenna, B, Bhaskaran, K, Rentsch, C T, Powell, E, Williamson, E, Croker, R, Bacon, S, Hulme, W, Bates, C, Curtis, H J, Mehrkar, A, Cockburn, J, McDonald, H I, Mathur, R, Wing, K, Forbes, H, Eggo, R M, Evans, S J W, Smeeth, L & Goldacre, B & Douglas, I J 2021, ' Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants : population-based cohort study ', Journal of Hematology and Oncology, vol. 14, no. 1, 172 . https://doi.org/10.1186/s13045-021-01185-0
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-10 (2021)
Wong, A Y S, Tomlinson, L A, Brown, J P, Elson, W, Walker, A J, Schultze, A, Morton, C E, Evans, D, Inglesby, P, MacKenna, B, Bhaskaran, K, Rentsch, C T, Powell, E, Williamson, E, Croker, R, Bacon, S, Hulme, W, Bates, C, Curtis, H J, Mehrkar, A, Cockburn, J, McDonald, H I, Mathur, R, Wing, K, Forbes, H, Eggo, R M, Evans, S J W, Smeeth, L & Goldacre, B & Douglas, I J 2021, ' Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants : population-based cohort study ', Journal of Hematology and Oncology, vol. 14, no. 1, 172 . https://doi.org/10.1186/s13045-021-01185-0
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-10 (2021)
Background Thromboembolism has been reported as a consequence of severe COVID-19. Although warfarin is a commonly used anticoagulant, it acts by antagonising vitamin K, which is low in patients with severe COVID-19. To date, the clinical evidence on
Publikováno v:
BMJ Open
ObjectiveTo assess the benefits and harms of pregabalin in the management of neuropathic pain.DesignRapid review and meta-analysis of phase III, randomised, placebo-controlled trials.ParticipantsAdults aged 18 years and above with neuropathic pain de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d50a6ea8760f3460d5344695b9235351
https://doi.org/10.1136/bmjopen-2018-023600
https://doi.org/10.1136/bmjopen-2018-023600
Publikováno v:
Heart
OBJECTIVE: To evaluate targeting of statin prescribing for primary prevention to those with high cardiovascular disease (CVD) risk. DESIGN: Two cohort studies including the general population and initiators of statins aged 35-74 years. SETTING: UK pr